编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
---|---|---|---|---|
010606 | Medetomidine hydrochloride | 86347-15-1 | 98% | ![]() |
Medetomidine Hydrochloride is an agonist of adrenergic alpha-2 receptor, which is use | ||||
010424 | MK-2048 | 870005-19-9 | 98% | ![]() |
MK-2048 is a second generation integrase inhibitor, intended to be used against HIV i | ||||
51627 | MK7622 | 1227923-29-6 | 98% by HPLC | ![]() |
MK-7622isused as adjunctive therapy to acetylcholinesterase inhibitors (AChEIs) for t | ||||
123007 | MK-4827 | 1038915-60-4 | 98% | ![]() |
MK-4827 is a selective inhibitor of PARP1/PARP2 with IC50 of 3.8 nM/2.1 nM; with grea | ||||
122949 | MK-0752 | 471905-41-6 | 98% | ![]() |
MK-0752 is a moderately potent -secretase inhibitor, which reduces A40 production wit | ||||
122819 | MK8745 | 885325-71-3 | 98% | ![]() |
MK-8745 is a novel Aurora-A specific inhibitor. MK8745 induced apoptotic cell death i | ||||
122217 | MK 886 | 118414-82-7 | 98% | ![]() |
MK 886 is a leukotriene antagonist. It may perform this by blocking the 5-lipoxygenas | ||||
122101 | ML216 | 1430213-30-1 | 98% | ![]() |
ML216 is a potent inhibitor of the DNA unwinding activity of BLM helicase; showing si | ||||
121508 | Masitinib | 790299-79-5 | 98% | ![]() |
Masitinib is a novel inhibitor for Kit and PDGFR/ with IC50 of 200 nM and 540 nM/800 | ||||
121504 | MK-5108 | 1010085-13-8 | 98% | ![]() |
MK-5108 is a highly selective Aurora A inhibitor with IC50 of 0.064 nM; 220- and 190- | ||||
121502 | Mandyphos SL-M004-1 | 494227-37-1 | 97% | ![]() |
Coming soon! | ||||
121425 | Marbofloxacin | 115550-35-1 | 98% | ![]() |
Marbofloxacin is a potent antibiotic of which depends upon its inhibition of DNA-gyra | ||||
120712 | Micafungin sodium | 208538-73-2 | 98% | ![]() |
Micafungin is an antifungal drug that belongs to the antifungal class of compounds kn | ||||
120703 | Memantine hydrochloride | 41100-52-1 | 98% | ![]() |
Coming soon! | ||||
5112803 | 1-(4-methoxybenzyl)-1H-pyrazolo[3,4-b]pyridin-4-ol | 924909-16-0 | 98% by HPLC at 254nm | ![]() |
1-(4-methoxybenzyl)-1H-pyrazolo[3,4-b]pyridin-4-ol | ||||
111305 | MCB-613 | 1162656-22-5 | 98% | ![]() |
Coming soon! | ||||
111303 | MG-132 | 133407-82-6 | 98% | ![]() |
MG-132 is an inhibitor of proteasome with IC50 of 100 nM, and also inhibits calpain w | ||||
111015 | Mocetinostat(MGCD0103) | 726169-73-9 | 98% by HPLC/HNMR | ![]() |
Mocetinostat is an orally-bioavailable, spectrum-selective HDAC inhibitor. Mocetinost | ||||
111013 | MGCD-265-analog | 875337-44-3 | ≧98.0% | ![]() |
MGCD-265-analogis a tyrosine kinase inhibitor that selectively targets MET and Axl.MG | ||||
102610 | MDL 28170 | 88191-84-8 | 98% | ![]() |
MDL 28170 is a potent, cell-permeable, and selective inhibitor of calpain and catheps | ||||
102207 | MI-773 | 1303607-60-4 | 98% | ![]() |
MI-773 is an orally available spiro-oxindole HDM2 (human double minute 2) antagonist | ||||
101915 | MK-0822 | 603139-19-1 | 98% | ![]() |
MK-0822 is an inhibitor of cathepsin K with potential anti-osteoporotic activity. It | ||||
101204 | ML204 | 5465-86-1 | 98% | ![]() |
ML204 is a novel potent antagonist that selectively modulates native TRPC4/C5 ion cha | ||||
92215 | methyl 2-formyl-1,3-thiazole-4-carboxylate | 921927-88-0 | 98% | ![]() |
Coming soon! | ||||
92213 | 5-(methoxycarbonyl)-1-tosyl-1Hpyrrol-3-yl-3-boronic acid | 916177-00-9 | 98% | ![]() |
Coming soon! | ||||
92203 | 2-Methyl-1-benzofuran-6-ol | 54584-24-6 | 98% | ![]() |
Coming soon! | ||||
91828 | 2-Methyl-1,3-oxazole-4-carboxylic acid | 23012-17-1 | 98% | ![]() |
Coming soon! | ||||
91809 | methyl 2-((1R,3S)-3-amino-1-hydroxy-4-methylpentyl)thiazole-4-carboxylate | 1265905-21-2 | 98% | ![]() |
Coming soon! | ||||
91802 | MK-5172 intermediate | 1206524-85-7 | 98% | ![]() |
MK-5172(Grazoprevir) intermediate | ||||
91801 | Methyl (1aR,5S,8S,10R,22aR)-5-tert-butyl-14-methoxy-3,6-dioxo- | 1206524-84-6 | 98% | ![]() |
MK-5172(Grazoprevir) intermediate |